Myelofibrosis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
| Line 27: | Line 27: | ||
:*[[Fluorosis]] | :*[[Fluorosis]] | ||
:*[[Mastocytosis]] | :*[[Mastocytosis]] | ||
:*[[Hepatitis C associated osteosclerosis]] (HCAO) | :*[[osteosclerosis|Hepatitis C associated osteosclerosis]] (HCAO) | ||
==References== | ==References== | ||
Revision as of 14:52, 11 March 2016
|
Myelofibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myelofibrosis differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Myelofibrosis differential diagnosis |
|
Risk calculators and risk factors for Myelofibrosis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2], Sujit Routray, M.D. [3]
Overview
Differentiating Myelofibrosis from other Diseases
Myelofibrosis must be differentiated from other diseases that cause diffuse bone sclerosis, such as:[1][2]
- Hematological causes
- Metabolic bone disorders
- Congenital
- Malignancy
- Lymphoma: infiltration
- Leukaemia: infiltration
- Osteoblastic metastases
- Other
References
- ↑ Differential diagnosis of myelofibrosis. Dr Henry Knipe and Dr Yuranga Weerakkody et al. Radiopaedia 2016. http://radiopaedia.org/articles/myelofibrosis. Accessed on March 10, 2016
- ↑ Diffuse bony sclerosis: differential diagnosis. Dr Craig Hacking and Dr Yuranga Weerakkody et al. Radiopaedia 2016. http://radiopaedia.org/articles/diffuse-bony-sclerosis-differential-diagnosis. Accessed on March 10, 2016